$250 Million is the total value of Altium Capital Management LP's 127 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | PEPPERLIME HEALTH ACQUSTN CO | $7,251,000 | – | 735,000 | +100.0% | 2.90% | – | |
| STAA | New | STAAR SURGICAL CO | $5,320,000 | – | 75,000 | +100.0% | 2.13% | – |
| New | QUIDELORTHO CORP | $4,859,000 | – | 50,000 | +100.0% | 1.94% | – | |
| GH | New | GUARDANT HEALTH INC | $4,236,000 | – | 105,000 | +100.0% | 1.70% | – |
| GH | New | GUARDANT HEALTH INCcall | $4,034,000 | – | 100,000 | +100.0% | 1.61% | – |
| CCXI | New | CHEMOCENTRYX INC | $3,965,000 | – | 160,000 | +100.0% | 1.59% | – |
| New | AMYLYX PHARMACEUTICALS INCput | $3,852,000 | – | 200,000 | +100.0% | 1.54% | – | |
| AKYA | New | AKOYA BIOSCIENCES INC | $3,804,000 | – | 296,000 | +100.0% | 1.52% | – |
| INGN | New | INOGEN INC | $3,772,000 | – | 156,000 | +100.0% | 1.51% | – |
| TRVI | New | TREVI THERAPEUTICS INC | $3,608,000 | – | 1,284,000 | +100.0% | 1.44% | – |
| KURA | New | KURA ONCOLOGY INC | $2,695,000 | – | 147,000 | +100.0% | 1.08% | – |
| MASS | New | 908 DEVICES INC | $2,574,000 | – | 125,000 | +100.0% | 1.03% | – |
| HRMY | New | HARMONY BIOSCIENCES HLDGS IN | $2,439,000 | – | 50,000 | +100.0% | 0.98% | – |
| GOSS | New | GOSSAMER BIO INC | $2,176,000 | – | 260,000 | +100.0% | 0.87% | – |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $2,145,000 | – | 22,000 | +100.0% | 0.86% | – |
| COLL | New | COLLEGIUM PHARMACEUTICAL INC | $2,056,000 | – | 116,000 | +100.0% | 0.82% | – |
| AXSM | New | AXSOME THERAPEUTICS INCput | $1,915,000 | – | 50,000 | +100.0% | 0.77% | – |
| RZLT | New | REZOLUTE INC | $1,328,000 | – | 411,000 | +100.0% | 0.53% | – |
| RXDX | New | PROMETHEUS BIOSCIENCES INC | $1,101,000 | – | 39,000 | +100.0% | 0.44% | – |
| New | HOLLEY INC | $840,000 | – | 80,000 | +100.0% | 0.34% | – | |
| New | PEPGEN INC | $794,000 | – | 80,000 | +100.0% | 0.32% | – | |
| ANGO | New | ANGIODYNAMICS INC | $767,000 | – | 39,640 | +100.0% | 0.31% | – |
| New | LIANBIOsponsored ads | $681,000 | – | 315,191 | +100.0% | 0.27% | – | |
| STOK | New | STOKE THERAPEUTICS INC | $634,000 | – | 48,000 | +100.0% | 0.25% | – |
| ATHA | New | ATHIRA PHARMA INCcall | $610,000 | – | 200,100 | +100.0% | 0.24% | – |
| GERN | New | GERON CORP | $576,000 | – | 371,367 | +100.0% | 0.23% | – |
| ALKS | New | ALKERMES PLC | $536,000 | – | 18,000 | +100.0% | 0.21% | – |
| SAGE | New | SAGE THERAPEUTICS INC | $485,000 | – | 15,000 | +100.0% | 0.19% | – |
| DBGI | New | DIGITAL BRANDS GROUP INC | $195,000 | – | 1,000,000 | +100.0% | 0.08% | – |
| BBIO | New | BRIDGEBIO PHARMA INCcall | $158,000 | – | 17,400 | +100.0% | 0.06% | – |
| New | SONENDO INC | $65,000 | – | 37,572 | +100.0% | 0.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FAT BRANDS INC | 12 | Q3 2023 | 0.6% |
| CHINOOK THERAPEUTICS INC | 11 | Q2 2023 | 8.9% |
| BELLUS HEALTH INC NEW | 10 | Q1 2023 | 4.7% |
| XTANT MED HLDGS INC | 10 | Q3 2023 | 5.1% |
| IVERIC BIO INC | 10 | Q1 2023 | 2.3% |
| MYRIAD GENETICS INC | 10 | Q1 2023 | 2.3% |
| HARBOR CUSTOM DEVELOPMENT IN | 10 | Q3 2023 | 0.1% |
| CRINETICS PHARMACEUTICALS IN | 9 | Q3 2023 | 4.1% |
| CTI BIOPHARMA CORP | 9 | Q1 2023 | 2.6% |
| POLISHED COM INC | 9 | Q2 2023 | 3.4% |
View Altium Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Marpai, Inc. | April 26, 2023 | 1,805,327 | 6.2% |
| Astria Therapeutics, Inc. | February 14, 2023 | 1,355,372 | 5.0% |
| HyreCar Inc. | February 14, 2023 | 1,688,120 | 5.6% |
| Muscle Maker, Inc. | February 14, 2023 | 2,888,085 | 5.0% |
| NeuroBo Pharmaceuticals, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| PALISADE BIO, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| 1847 Goedeker Inc. | February 14, 2022 | 6,103,824 | 5.0% |
| BioRestorative Therapies, Inc. | February 14, 2022 | 200,000 | 5.0% |
| BriaCell Therapeutics Corp. | February 14, 2022 | 900,000 | 4.7% |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | February 14, 2022 | 363,000 | 5.0% |
View Altium Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-02-21 |
| SC 13G | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View Altium Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.